HHS and the Steven & Alexandra Cohen Foundation Announce the Phase 2 Interim Prize Awards
10.04.2023 |
arrow_forward
LymeX Diagnostics Prize Launches Phase 2 with a Virtual Accelerator
02.02.2023 |
arrow_forward
$10 Million LymeX Diagnostics Prize Launches to Improve Lyme Disease Testing
05.18.2022 |
arrow_forward
LymeX Diagnostics Prize
01.07.2022 |
arrow_forward
LymeX Diagnostics Prize
01.01.2022 |
arrow_forward
Centers for Disease Control – FY 22 Broad Agency Announcement
12.06.2021 |
arrow_forward
A hope for Lyme disease? New vaccine targets ticks
11.17.2021 |
arrow_forward
LymeX Exemplifies the Power of Partnerships after One Year of Progress
10.20.2021 |
arrow_forward
Luminary Labs to Design LymeX Diagnostics Moonshot
09.17.2021 |
arrow_forward
HHS Pioneers an Innovation Model for the Complex Challenge of Lyme Disease
04.26.2021 |
arrow_forward
Public-private partnership between HHS, Steven & Alexandra Cohen Foundation yields $25M LymeX innovation accelerator
10.14.2020 |
arrow_forward{"post_type":"post","orderby":"date","order":"DESC","posts_per_page":"12","category__in":""}